1. Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS). (18th March 2019) Authors: Marschner, N.; Frank, M.; Vach, W.; Ladda, E.; Karcher, A.; Winter, S.; Jänicke, M.; Trarbach, T. Journal: Colorectal disease Issue: Volume 21:Number 7(2019) Page Start: 816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB. (23rd June 2022) Authors: Marschner, N.; Hanselmann, J.; McGough, S.; Braun, S.; Pfizler-Dempfle, S.; Sandner, R.; Mohm, J.; Jaber, M.; Hamm, D.; Hamm, N.; Jaenicke, M.; Shewade, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system. (October 2020) Authors: Schmidt, M.; Degenhardt, T.; Fasching, P.A.; Lüftner, D.; Müller, V.; Thomssen, C.; Schem, C.; Witzel, I.; Decker, T.; Tesch, H.; Kümmel, S.; Uleer, C.; Würstlein, R.; Hoffmann, O.; Warm, M.; Marschner, N.; Kates, R.E.; Schumacher, J.; Harbeck, N. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ribociclib + letrozole for first-line treatment of HR+, HER2− ABC: efficacy, safety, and pharmacokinetics. (December 2016) Authors: André, F.; Stemmer, S.M.; Hortobagyi, G.N.; Burris, H.A.; Paluch-Shimon, S.; Campone, M.; Villanueva, C.; Chan, A.; Wist, E.; Marschner, N.; Bachelot, T.; Blau, S.; Janni, W.; Verma, S.; Conte, P.; Dhuria, S.; Yang, S.; Stegert, M.; Germa, C.; Arteaga, C.L. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SANDOZ RITUXIMAB FOR TREATMENT OF DIFFUSE LARGE B‐CELL LYMPHOMA: INTERIM SAFETY RESULTS OF THE NON‐INTERVENTIONAL, OBSERVATIONAL, MULTICENTER, OPEN‐LABEL REFLECT STUDY. (12th June 2019) Authors: Welslau, M.; Marschner, N.; Wolff, T.; Otremba, B.; Topaly, J.; Bittencourt da Silva, L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗